Video

Dr. Wong on treatment sequence in metastatic urothelial carcinoma

Author(s):

Urology Times staff

Current Time 0:00
Duration 0:00
Loaded: 0%
Stream Type LIVE
Remaining Time 0:00
 
1x
    • Chapters
    • descriptions off, selected
    • captions off, selected

      Risa Wong, MD, discusses the sequencing of treatments in the metastatic urothelial carcinoma armamentarium, including chemotherapy, immune checkpoint inhibitors, and antibody-drug conjugates. Wong is a hematology/oncology fellow at the University of Washington and Fred Hutchinson Cancer Research Center in Seattle.

      Related Videos
      4 experts in this video
      Non–Muscle Invasive-Bladder Cancer Overview
      Laura Davis, MD, on link between microplastics and bladder cancer
      Laura Davis, MD, on link between microplastics and bladder cancer
      Rebecca A. Campbell, MD, answers a question during a Zoom video interview
      Rebecca A. Campbell, MD, discusses citation rates for men and women in the oncology literature
      Sam Chang, MD, shares updated data on nogapendekin alfa inbakicept in NMIBC
      Sam Chang, MD, shares updated data on nogapendekin alfa inbakicept in NMIBC
      Joshua J. Meeks, MD, PhD, gives an answer during a Zoom video interview
      Expert discusses the NMIBC trials landscape
      John Gore, MD, on bladder preservation in muscle–invasive bladder cancer
      John Gore, MD, on bladder preservation in muscle–invasive bladder cancer
      Félix Guerrero-Ramos, MD, on TAR-200 in papillary disease-only NMIBC
      Félix Guerrero-Ramos, MD, on TAR-200 in papillary disease-only NMIBC
      Joshua J. Meeks, MD, PhD, answers a question during a Zoom video interview
      Joshua J. Meeks, MD, PhD, discusses NIAGARA data for patient undergoing cystectomy
      Joseph Jacob, MD, on the durability of TAR-200 in NMIBC
      Joseph Jacob, MD, on the durability of TAR-200 in NMIBC
      Study data point to gender disparities in oncology research citations
      Study data point to gender disparities in oncology research citations
      Related Content
      Urologic surgeons successfully complete world’s first bladder transplant
      May 19th 2025

      Urologic surgeons successfully complete world’s first bladder transplant

      Hannah Clarke
      The bladder transplant procedure involved a collaboration between the University of California, Los Angeles and the University of Southern California.
      medical depiction of bladder cancer
      May 31st 2023

      Bladder Cancer Awareness Month: Dr. Kamat highlights the state of bladder cancer care

      Urology Times staff
      In this episode, Ashish M. Kamat, MD, MBBS, highlights the state of bladder cancer care in recognition of Bladder Cancer Awareness Month.
      Disitamab vedotin plus toripalimab extends PFS, OS in HER2-positive la/mUC
      May 12th 2025

      Disitamab vedotin plus toripalimab extends PFS, OS in HER2-positive la/mUC

      Hannah Clarke
      The phase 3 RC48-C016 trial met its primary end points.
      Speaking of Urology Podcast: Dr. Ritch and Dr. Katz discuss new bladder cancer management app
      December 7th 2021

      Speaking of Urology Podcast: Dr. Ritch and Dr. Katz discuss new bladder cancer management app

      Urology Times staff
      “It's not a replacement for clinical judgment, obviously. But at the end of the day, the idea is that it shows you what your next steps are based on what the American Urological Association and [Society of Urologic Oncology] guidelines are for non-muscle invasive bladder cancer,” Chad R. Ritch, MD, MBA, FACS.
      Physical function and frailty measures offer distinct insights in patients with bladder cancer
      May 7th 2025

      Physical function and frailty measures offer distinct insights in patients with bladder cancer

      Hannah Clarke
      Data showed that physical function and self-reported frailty assessments were poorly correlated.
      FDA to host advisory committee meeting on UGN-102 for NMIBC
      May 7th 2025

      FDA to host advisory committee meeting on UGN-102 for NMIBC

      Hannah Clarke
      The Oncologic Drugs Advisory Committee meeting is scheduled for May 21, 2025.
      © 2025 MJH Life Sciences

      All rights reserved.